Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.

about

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.

Item

http://www.wikidata.org/entity/Q38612748

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.

@en

type

Item

label

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.

@en

altLabel

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV

@en

prefLabel

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV.

@en

P1476

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV

@en

P2093

Christian Marsolais

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Mamputu

http://www.w3.org/2001/XMLSchema#string

Josée Morin

http://www.w3.org/2001/XMLSchema#string

Julian Falutz

http://www.w3.org/2001/XMLSchema#string

Julian Weiss

http://www.w3.org/2001/XMLSchema#string

Lindsay T Fourman

http://www.w3.org/2001/XMLSchema#string

Meghan N Feldpausch

http://www.w3.org/2001/XMLSchema#string

Natalia Czerwonka

http://www.w3.org/2001/XMLSchema#string

Steven K Grinspoon

http://www.w3.org/2001/XMLSchema#string

P2860

Mildly elevated liver transaminase levels in the asymptomatic patient.

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons

Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial

Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study

Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals.

Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.

Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.

Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.

Updated definitions of healthy ranges for serum alanine aminotransferase levels.

P304

2253-2259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001614

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takara L Stanley

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28832410

http://www.w3.org/2001/XMLSchema#string

P932

5633509

http://www.w3.org/2001/XMLSchema#string